Official websites use .gov
A .gov website belongs to an official government
organization in the United States.
Secure .gov websites use HTTPS
A lock (🔒) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.
Division of Allergy, Immunology, and Transplantation High-Priority Areas of Interest for Small Business | NIAID
Image
NIAID encourages Small Business applications that focus on asthma and allergies, autoimmune disease, the immune system, radiation exposure, and transplantation.
The following topics from the Division of Allergy, Immunology, and Transplantation (DAIT) are NIAID Small Business Program high-priority areas of interest. If you do not see your allergy-, immunology-, or transplantation-related topic here, your funding application will still be reviewed, but it may not be prioritized.
If you have questions about these research topics or seek advice on the application process, please contact the specific subject matter experts listed below. You may contact Michael Minnicozzi with questions if a subject matter expert is not listed.
Asthma and Allergies
Topics
Areas of Interest
Subject Matter Experts
Detection
Novel approaches for detecting infants at risk for developing asthma and other allergic diseases.
Alkis Togias , Allergy, Asthma, and Airway Biology Branch
Diagnosis
Developing food allergy diagnostic testing that can replace oral food challenges.
Adora Lin , Allergy, Asthma, and Airway Biology Branch
New forms of allergen immunotherapy for food allergies, allergic rhinitis, and asthma
Novel therapies that offer improved efficacy, safety, and a faster induction of clinical tolerance (i.e., the state where the effect of immunotherapy remains after therapy is discontinued).
Reagents for immunological analysis of non-mammalian and underrepresented mammalian models
Development and validation of reagents (e.g., antibodies, proteins, molecular probes) for the characterization of immune cells and their responses—targeted species include non-mammalian models (e.g., arthropods, amphibians, fish, nematodes, marine echinoids) and underrepresented mammalian models (e.g., guinea pig, ferret, cotton rat, bat, pig, marmoset).
Development of medical countermeasures to protect against, mitigate, and treat the short- and long-term effects of radiation exposure due to terrorist attack.
Development of novel or improved decorporation agents to remove radionuclides from the body following accidental inhalation, ingestion, or wound entry.